Bing Liu

11.7k total citations · 1 hit paper
224 papers, 5.1k citations indexed

About

Bing Liu is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Bing Liu has authored 224 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Oncology, 58 papers in Molecular Biology and 57 papers in Immunology. Recurrent topics in Bing Liu's work include Immune Cell Function and Interaction (30 papers), Zebrafish Biomedical Research Applications (25 papers) and Single-cell and spatial transcriptomics (16 papers). Bing Liu is often cited by papers focused on Immune Cell Function and Interaction (30 papers), Zebrafish Biomedical Research Applications (25 papers) and Single-cell and spatial transcriptomics (16 papers). Bing Liu collaborates with scholars based in China, United States and Japan. Bing Liu's co-authors include Yu Lan, Yanli Ni, Zongcheng Li, Wenyan He, Zhijie Bai, Julie E. Goodwin, Jian He, Tie‐Ning Zhang, Pengcheng Zhang and Yandong Gong and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Bing Liu

213 papers receiving 5.0k citations

Hit Papers

Cyclooxygenase-2-Prostaglandin E2 pathway: A key player i... 2023 2026 2024 2025 2023 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bing Liu China 39 1.9k 1.3k 1.3k 729 551 224 5.1k
Martina Rauner Germany 48 3.5k 1.8× 1.9k 1.4× 917 0.7× 985 1.4× 440 0.8× 240 7.3k
Peter Petzelbauer Austria 45 2.0k 1.0× 1.4k 1.1× 1.8k 1.5× 537 0.7× 393 0.7× 146 6.1k
Fan Dong China 46 2.1k 1.1× 1.5k 1.1× 1.4k 1.1× 890 1.2× 247 0.4× 172 6.3k
Liu C United States 54 3.8k 1.9× 1.1k 0.8× 1.2k 0.9× 1.3k 1.8× 643 1.2× 265 8.4k
Zhaojun Liu China 38 3.2k 1.6× 1.3k 1.0× 1.3k 1.0× 843 1.2× 394 0.7× 177 6.5k
Shuli Li United States 46 2.1k 1.1× 1.2k 0.9× 1.2k 0.9× 657 0.9× 1.3k 2.3× 239 6.9k
Aurora Astudillo Spain 43 2.6k 1.3× 1.4k 1.0× 623 0.5× 1.3k 1.8× 337 0.6× 171 5.9k
Rainer M. Bohle Germany 46 2.5k 1.3× 804 0.6× 988 0.8× 815 1.1× 397 0.7× 221 6.5k
Stefania Mitola Italy 36 2.8k 1.4× 799 0.6× 894 0.7× 729 1.0× 606 1.1× 111 4.9k
Je‐Yoel Cho South Korea 40 3.1k 1.6× 1.1k 0.8× 642 0.5× 959 1.3× 283 0.5× 165 5.5k

Countries citing papers authored by Bing Liu

Since Specialization
Citations

This map shows the geographic impact of Bing Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Liu more than expected).

Fields of papers citing papers by Bing Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bing Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Liu. The network helps show where Bing Liu may publish in the future.

Co-authorship network of co-authors of Bing Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Bing Liu. A scholar is included among the top collaborators of Bing Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bing Liu. Bing Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yonghua, Weijie Li, Simin Liu, et al.. (2025). Targeting chaperone-mediated autophagy inhibits properties of glioblastoma stem cells and restores anti-tumor immunity. Nature Communications. 17(1). 440–440.
3.
Liu, Bing, et al.. (2024). An Evaluation Mechanism of LLM-based Agents on Manipulating APIs. 4649–4662. 2 indexed citations
4.
Liu, Mingxu, Bing Liu, Mengmeng Li, et al.. (2024). Impact of Oversimplified Parameters on BVOC Emissions Estimation in China: A Sensitivity Analysis Using the WRF‐CLM4‐MEGAN Model. Journal of Geophysical Research Biogeosciences. 129(11). 1 indexed citations
6.
Xiao, Fengfeng, Yongkang Liu, Yanhong Su, et al.. (2024). Biodegradable Poly(amino acid)–Bismuth Nanotheranostic Agents for CT/MR Imaging and Photothermal–Chemodynamic Synergistic Therapy. SHILAP Revista de lepidopterología. 1(5). 448–460. 9 indexed citations
7.
Liu, Bing, Wenyan Guan, Ziyao Liu, et al.. (2024). Advancing precision medicine in esophageal squamous cell carcinoma using patient-derived organoids. Journal of Translational Medicine. 22(1). 1168–1168. 3 indexed citations
8.
Wang, Hanqi, et al.. (2023). Advances in CAR-T Cell Therapy in Head and Neck Squamous Cell Carcinoma. Journal of Clinical Medicine. 12(6). 2173–2173. 20 indexed citations
9.
Ma, Xiuxiu, Meng Wang, Fan Wang, et al.. (2023). High resolution crystal structure of BRD4-BD1 in complex with a novel inhibitor precursor. Biochemical and Biophysical Research Communications. 690. 149284–149284. 1 indexed citations
10.
Szymula, Agnieszka, Sidney Ogolla, Bing Liu, et al.. (2023). Macrophages drive KSHV B cell latency. Cell Reports. 42(7). 112767–112767. 13 indexed citations
11.
Sun, Zhipeng, Bing Liu, Bin Shu, et al.. (2023). Clinical characteristics of solitary intrahepatic biliary cyst. BioScience Trends. 17(5). 409–412.
12.
Liu, Chao, Min Zhang, Xinlong Yan, et al.. (2023). Single-cell dissection of cellular and molecular features underlying human cervical squamous cell carcinoma initiation and progression. Science Advances. 9(4). eadd8977–eadd8977. 65 indexed citations
13.
Wang, Yan, Bing Liu, Qingjie Min, et al.. (2023). Spatial transcriptomics delineates molecular features and cellular plasticity in lung adenocarcinoma progression. Cell Discovery. 9(1). 96–96. 34 indexed citations
14.
Zheng, Zhaofeng, Han He, Xinyu Tang, et al.. (2022). Uncovering the emergence of HSCs in the human fetal bone marrow by single-cell RNA-seq analysis. Cell stem cell. 29(11). 1562–1579.e7. 23 indexed citations
15.
Yan, Mingjing, Yuan Cao, Que Wang, et al.. (2022). miR‐488‐3p Protects Cardiomyocytes against Doxorubicin‐Induced Cardiotoxicity by Inhibiting CyclinG1. Oxidative Medicine and Cellular Longevity. 2022(1). 5184135–5184135. 12 indexed citations
16.
Du, Meng, Liu Yang, Bing Liu, et al.. (2021). Inhibition of NFAT suppresses foam cell formation and the development of diet‐induced atherosclerosis. The FASEB Journal. 35(10). e21951–e21951. 10 indexed citations
17.
Xu, Man, Ruoling Chen, Li Liu, et al.. (2021). Systemic immune-inflammation index and incident cardiovascular diseases among middle-aged and elderly Chinese adults: The Dongfeng-Tongji cohort study. Atherosclerosis. 323. 20–29. 132 indexed citations
18.
Thomas, Jake, Xiaohui Zhao, Colin Y.C. Lee, et al.. (2020). Phenotypic and functional characterization of first-trimester human placental macrophages, Hofbauer cells. The Journal of Experimental Medicine. 218(1). 115 indexed citations
20.
Liu, Yi, Shaohua Zhang, Tao Wang, et al.. (2014). [Detection of circulating tumor cells and its clinical value for different stages and various subtypes of breast cancer].. PubMed. 94(36). 2812–5. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026